Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akari Therapeutics PLC

1.28
+0.07506.22%
Post-market: 1.280.00000.00%16:00 EDT
Volume:91.27K
Turnover:103.12K
Market Cap:36.96M
PE:-0.52
High:1.29
Open:1.29
Low:1.03
Close:1.21
Loading ...
Aug 20, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 20, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 19, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 07, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations